Simple blood test may cut heart failure readmissions
NCT ID NCT02963272
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 33 times
Summary
This study looked at whether measuring a substance called ST2 in the blood can help doctors better diagnose and manage heart failure. Researchers followed 123 patients hospitalized for heart failure to see if using ST2 levels could reduce the number of patients readmitted within one month. The goal is to improve care and lower healthcare costs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Regional Hospital Arnaud de Villeneuve
Montpellier, Languedoc-Roussillon, 34295, France
Conditions
Explore the condition pages connected to this study.